Advertisement

Organisation › Details
Wellington Partners (Group)
Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totalling more than €1.2 billion, thereof €590 million committed to life sciences, Wellington Partners has been actively supporting world class private companies translating true innovation into successful businesses with exceptional growth. To date, Wellington Partners has invested in 56 innovative life science companies, including Actelion (acquired by J&J), Definiens (acquired by AZ), immatics (Nasdaq: IMTX). invendo (acquired by Ambu), MTM Laboratories (acquired by Roche/Ventana), Oxford Immunotec (acquired by PerkinElmer), Rigontec (acquired by MSD), Symetis (acquired by Boston Scientific), and Themis (acquired by MSD). *
![]() |
Start | 1998-01-01 established |
Today | Wellington Partners Venture Capital GmbH | |
![]() |
Industry | venture capital |
Industry 2 | LIFE SCIENCES | |
![]() |
Person | Strohmenger, Rainer (Wellington Partners Venture Capital 201303 General Partner) |
Person 2 | Essig, Stuart M. (Wellington Partners 201303– Venture Partner before Integra Life Sciences CEO + Goldman Sachs) | |
![]() |
Region | München (Munich) |
Country | Germany | |
Street | 5 Türkenstr. | |
City | 80333 München | |
Tel | +49-89-219941-0 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 1,200,000,000 (fund size (2022) 2022-09-15) | |
* Document for »About Section«: Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Wellington Partners (Group)
- [1] Sofinnova Partners. (9/10/24). "Press Release: Sofinnova Partners Appoints Karl Naegler as Partner". Paris....
- [2] Seamless Therapeutics GmbH. (3/16/23). "Press Release: Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases". Dresden....
- [3] Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin....
- [4] Adrenomed AG. (1/4/21). "Press Release: Adrenomed Supervisory Board Appoints Dr. Wolfgang Baiker as CEO". Hennigsdorf....
- [5] Adrenomed AG. (11/30/20). "Press Release: Adrenomed Closes EUR 22 Million Equity Financing to Accelerate Development of Adrecizumab (HAM8101) and Provides Business Update". Hennigsdorf....
- [6] Sidekick Health. (10/28/20). "Press Release: Sidekick Raises $20M in Series A Funding Round Led by Wellington and Asabys". Barcelona, Munic & Reykjavik....
- [7] NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel....
- [8] Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich....
- [9] Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund"....
- [10] Confo Therapeutics N.V.. (5/7/19). "Press Release: Confo Therapeutics Raises €30 Million in Series A Financing". Ghent....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top